NCT04196374View on ClinicalTrials.gov

Return of Genomic Results and Aggregate Penetrance in Population-Based Cohorts

NAEnrolling by invitationINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

June 9, 2021

Primary Completion Date

June 30, 2024

Study Completion Date

June 30, 2025

Conditions
Seemingly HealthyGenetic Predisposition to Disease
Interventions
GENETIC

Genomic Sequencing

Whole Genome Sequencing and reporting of actionable genomic results for genes included on the ACMG secondary findings list.

Trial Locations (2)

39213

Jackson Heart Study, Jackson

01702

Framingham Heart Study, Framingham

Sponsors

Collaborators (1)

Partners HealthCare
All Listed Sponsors
collaborator

Framingham Heart Study

UNKNOWN

collaborator

Jackson Heart Study

UNKNOWN

collaborator

Broad Institute of MIT and Harvard

OTHER

collaborator

University of Mississippi Medical Center

OTHER

collaborator

Boston University

OTHER

collaborator

Partners HealthCare

OTHER

lead

Brigham and Women's Hospital

OTHER